DIA Annual Canadian Meeting

Short Courses: October 29
Meeting: October 30-31

The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.

Bringing together key stakeholders from the drug (innovator and generic/biosimilar)/, device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss/analyze the relevant challenges and opportunities for professionals working in the field in Canada.

This year’s meeting will feature preconference short courses, plenary sessions, multi-track breakout sessions and multiple networking opportunities.

Professionals in pharmaceutical and device industries, regulatory agencies, and academia involved in:

• clinical data management/eClinical
• comparative effectiveness/health technology assessment
• clinical safety/pharmacovigilance
• clinical research
• document management/eSubmissions
• medical communications
• outsourcing
• project management
• public policy/law/corporate compliance
• quality assurance control
• regulatory affairs
• research and development
• statistics

At the conclusion of this meeting,, participants should be able to:

• Describe the current and evolving regulatory environment in Canada
• Summarize methods and approaches in various aspects of clinical trials, patient engagement, and market access
• Discuss more in-depth, approaches on international harmonization, worksharing, and adoption of guidelines
• Review the various levels of transparency and post-market activities that are underway